- Type / Class
- Equity / COM
- Total 13F shares
- 1,292,104
- Share change
- +258,914
- Total reported value
- $1,395,296
- Price per share
- $1.08
- Number of holders
- 16
- Value change
- +$279,448
- Number of buys
- 10
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 016744500?
CUSIP 016744500 identifies ALLR - Allarity Therapeutics, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 016744500:
Top shareholders of ALLR - Allarity Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Private Advisor Group, LLC |
13F
|
Company |
—
class O/S missing
|
278,949
|
$440,739 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
246,708
|
$389,799 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
151,927
|
$240,044 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
137,600
|
$217,408 | — | 30 Sep 2025 | |
| Alexander Epshinsky |
3/4/5
|
CFO |
—
class O/S missing
|
85,051
|
$179,458 | — | 22 Jan 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
94,142
|
$148,744 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
66,186
|
$104,574 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
43,626
|
$68,929 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
—
class O/S missing
|
13,910
|
$21,978 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
134
|
$212 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
—
class O/S missing
|
7
|
$10 | — | 30 Sep 2025 | |
| DANSKE BANK A/S |
13F
|
Company |
—
class O/S missing
|
1
|
$2 | — | 30 Sep 2025 | |
| Leon Sass* |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,086,238
|
— | — | 20 Dec 2021 | |
| Steen Knudsen |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
124,976
|
— | — | 20 Dec 2021 | |
| Joseph Walter Vazzano |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 22 Jan 2025 | |
| Laura Benjamin |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 22 Jan 2025 | |
| Duncan Moore |
3/4/5
|
Director |
—
class O/S missing
|
22,672
|
— | — | 20 Dec 2021 | |
| Marie Foegh |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
3,988
|
— | — | 20 Dec 2021 | |
| Soren Gade Jensen |
3/4/5
|
Director |
—
class O/S missing
|
2,800
|
— | — | 20 Dec 2021 |
Institutional Holders of Allarity Therapeutics, Inc. - COM (ALLR) as of Q4 2025
As of 31 Dec 2025,
Allarity Therapeutics, Inc. - COM (ALLR) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,292,104 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DRW Securities, LLC, CAPITAL ADVISORS INC/OK, CITADEL ADVISORS LLC, Private Advisor Group, LLC, XTX Topco Ltd, and NORTHERN TRUST CORP.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
11
Q4 2025 holders
16
Holder diff
5
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.